Surgery

Oculis announces first patient enrolled in Phase 3 OPTIMIZE trial

OCS-01 is being reviewed for the treatment of inflammation and pain after cataract surgery, with the potential to become the first once-daily, topical and preservative-free corticosteroid for treating inflammation and pain following ocular surgery.

Self-plugging microneedles offer potential to improve delivery of drugs into the eye

How quality vision builds a foundation for safety and everyday activities

As ophthalmologists observe Cataract Awareness Month this June, William L. Soscia, MD, medical director at Center for Sight, in Sarasota, Florida, focuses on the importance of having excellent vision for safety and everyday functions.